Proposed changes to R&D incentives may not be bitter pill for drug industry

Taxation Laws Amendment Bill provides for inclusion of R&D in respect of generic medicine, and qualification of clinical medical trial expenses incurred in R&D

Powered by WPeMatico

This entry was posted in Business. Bookmark the permalink.

Comments are closed.